Podcasts about aperiomics

On this episode of the Startup of the Year Podcast, Frank Gruber, Co-Founder and Co-CEO of Established and Co-Founder of Established Ventures, introduces an Alumni Spotlight Panel discussion from our 2020 Summit, hosted by our very own COO, John Guidos. The alumni panel included the CEO and Co-Founder of Aperiomics, Crystal Icenhour. We also hear from Dawn Dickson-Akpoghene from Flat Out of Heels and PopCom. The panel also included Cooper Harris, the Founder and CEO of Klickly, which is also an Established Ventures portfolio company. And finally, we also hear from Samantha Snabes from re:3D, the 2019 winner. BIG NEWS!! Our good friend and the CEO of Embarc Collective, Lakshmi Shenoy, shares exciting info about this year's Summit! You can register today for tickets at: summit.startupofyear.com We also once again talk about TaxTaker, which offers an easy to use tech solution that helps startups claim R&D tax credits and earn back tens of thousands of dollars or more every year. They're on a mission to help startups and founders fuel their growth efforts so they can continue doing what they do best - building awesome companies and changing the world. Get started now for free at TaxTaker.com/SOTY. Lastly, we invite you all to join our community today to access the support, expert advice, and resources you need to elevate your startup by going to: est.us/join Thank you for listening, and as always, please check out the Established website and subscribe to the newsletter at www.est.us Checkout Startup of the Year at www.startupofyear.com Subscribe to the Startup of the Year Daily Deal Flow: www.startupofyear.com/daily-dealflow Subscribe to the Startup of the Year podcast: www.podcast.startupofyear.com Subscribe to the Established YouTube Channel: soty.link/ESTYouTube  *** Startup of the Year helps diverse, emerging startups, founding teams, and entrepreneurs push their company to the next level. We are a competition, a global community, and a resource. Startup of the Year is also a year-long program that searches the country for a geographically diverse set of startups from all backgrounds and pulls them together to compete for the title of Startup of the Year. The program includes a number of in-person and virtual events, including our annual South By Southwest startup pitch event and competition. All of which culminate at our annual Startup of the Year Summit, where the Startup of the Year winner is announced, along with an opportunity at a potential investment. Established is a consultancy focused on helping organizations with innovation, startup, and communication strategies. It is the power behind Startup of the Year. Created by the talent responsible for building the Tech.Co brand (acquired by an international publishing company), we are leveraging decades of experience to help our collaborators best further (or create) their brand & accomplish their most important goals. Connect with us on Twitter - @EstablishedUs and Facebook - facebook.com/established.us/.

On this week's Tech Nation, Moira speaks with UC San Francisco professor Dr. Louise Aronson talks about a new stage of life: Elderhood, – Redefining Aging, Transforming Medicine, Reimaging Life. With modern technology, it lasts longer than anyone imagined. Also, Tech Nation Health Chief Correspondent Daniel Kraft talks about the Internet of Medical Things, while Dr. Crystal Icenhour, the CEO of Aperiomics, talks about identifying hard-to-diagnose medical conditions by looking at the DNA of microorganisms in your body.

On this week’s Tech Nation, Moira speaks with UC San Francisco professor Dr. Louise Aronson talks about a new stage of life: Elderhood, – Redefining Aging, Transforming Medicine, Reimaging Life. With modern technology, it lasts longer than anyone imagined. Also, Tech Nation Health Chief Correspondent Daniel Kraft talks about the Internet of Medical Things, while Dr. Crystal Icenhour, the CEO of Aperiomics, talks about identifying hard-to-diagnose medical conditions by looking at the DNA of microorganisms in your body.

Public health officials have argued that thorough and accurate testing for SARS-CoV-2 is essential for gaining a foothold in the fight against the deadly COVID-19 pandemic. To date, however, a lack of reliable testing in the United States has hampered efforts to achieve a thorough understanding of the disease's abundance and spread. In this episode of BioScience Talks, we are joined by Dr. Crystal Icenhour, CEO of Aperiomics, and Dr. Robbie Barbero, Chief Business Officer of Ceres Nanosciences. Both companies have recently ramped up efforts to improve the prospects of broad-scale testing for the novel pathogen in human patients. Aperiomics, whose core technology uses deep shotgun metagenomic sequencing to test for tens of thousands of bacteria, virus, fungus, and parasite at once, has launched a SARS-CoV-2-specific test, with the aims of increasing test availability and delivering crucially important public health data. Ceres Nanosciences's flagship Nanotrap particle technology enables the capture, concentration, and preservation of low abundance analytes from complex biological samples. The technology is presently being tested with the SARS-CoV-2 and is expected to help in improving the accuracy of existing testing protocols. Image credit: NIAID-RML, CC BY 2.0. Learn more about Ceres Nanosciences. Learn more about Aperiomics. Listen to Dr. Icenhour's earlier appearance. Subscribe on iTunes. Subscribe on Stitcher. Catch up with us on Twitter.  

We spoke with Dr. Crystal Icenhour of Aperiomics. Aperiomics is a Loudoun-based company that has made great strides forwarding diagnosis tools in the identification of parasites. Over the past few weeks, they have shifted operations to creating covid-19 tests. Dr. Crystal Icenhour is one of the rising stars of American biotechnology. After more than 25 years in medical research and biotech, she was named founding CEO of Aperiomics, a company that harnesses the power of next-generation DNA sequencing to identify any known pathogen (bacteria, virus, fungi or parasite). Aperiomics is the only company of its kind and scope in the world. Throughout Dr. Icenhour’s career, she has demonstrated strong leadership in business and science and has dedicated herself to “bridging the translational gap between these two worlds.”

Do you have a parasite, a virus, or unknown infection? Maybe.   […] The post Break The Rules #78: When Doctors Can't Find What's Wrong with Dr. Crystal Icenhour, CEO of Aperiomics appeared first on Meet Dr. Lauryn.

Do you have a parasite, a virus, or unknown infection? Maybe.   Dr. Crystal Icenhour wanted to help her grandmother overcome several complex illnesses that no doctor could solve.   She knew there was a root cause...just the current testing available couldn't help figure it out. Dr. Icenhour decided to create it, and help others [...]

  Dr. Crystal Icenhour is the founding CEO of Aperiomix, a precision infection testing company at the intersection of high tech and biotech. Aperiomics is a service company identifying every known bacteria, DNA virus, parasite, and fungus in one test. This technology is a novel combination of genomics and informatics transforming infectious disease diagnostics and saving lives. Dr. Icenhour is also the Principal of Icenhour Biotech, a consulting firm focused on providing support to the biotechnology community in the areas of leadership, innovation, and commercialization. Her professional goal is to bridge the translational gap between the worlds of business and science. She’s committed to improving patient health through better infectious disease testing. Dr. Icenhour earned her Ph.D., Pathobiology and Molecular Medicine in 2002 from the University of Cincinnati College of Medicine. She served as a senior postdoctoral fellow at Duke University Health System and a research fellow at the Mayo Clinic. She also attended the University of Tulsa where she earned her Bachelor’s Degree in Biology. What You’ll Hear On This Episode of When Science Speaks [01:00] Mark introduces his guest, Dr. Crystal Icenhour [02:51] Dr. Icenhour explains about why scientist struggle to commercialize their work [05:03] What made Dr. Icenhour interested in innovating pathogen diagnostic and gin fighting infection [07:27] Dr. Icenhour talks about why she’s interested in many different fields [11:03] Dr. Icenhour’s three-piece advice for people who want to start or join a science-based company [13:33] Dr. Icenhour shares how you can build a good network through conversations that connect people to you at a personal level [17:14] Dr. Icenhour describes the biotech industry in Virginia and where she can see it heading [22:18] Dr. Icenhourl talks about her career highlights and the challenges she faced along the way Connect with Crystal Icenhour Aperiomics Crystal’s Linkedin The Struggle to Commercialize Science There is a fundamental difference between the scientific work that is done in an academic setting and one that can be used for purposes of business and entrepreneurship. While the ultimate goal of academic scientific research is the pursuit of knowledge, it’s quite a different ball game when you put science in the world of business. Because science in business means serving the needs and wants of the market. According to Dr. Crystal Icenhour the transition of turning scientific research into a viable market product can be a struggle for the many scientists who are able to make breakthroughs but lack funding and support. Dr. Icenhour is passionate about bridging the translational gap between science and business and her scientific accomplishments and entrepreneurial milestones offer a unique success story of the transition from the discovery of knowledge into application for profits in business. Balancing your time, identifying your skills and your strengths are crucial in making it work but when you do get the work going, the business will start growing. Gaining confidence to make the transition from academics to corporate The idea of transitioning from the space of academic and research science to using science for entrepreneurial purposes can be daunting. But with the right network and support, you can make an easy transition and find a way to meld them together to create a unique space for innovations that can help a lot of people. And one of the key elements to building that network is by opening yourself up to the prospect of meeting new people who will resound with the vision you have in mind. Networking can be difficult for introverts but it’s not impossible. In fact, introverts have the unique capacity of holding key leadership roles because they have the ability to listen well and to empathize with people which is very important when you want to bring people into your fold. Build your network by creating conversations that bring a more personal side of you that encourages connections and flavor discussions with just the right amount of information that will keep the person interested in making the conversation last longer. The Outlook of The Biotech Industry in Virginia  STEM professionals will be pleasantly surprised that the biotech industry in Virginina is more robust than what people perceive it to be. There is so much room for growth and innovations in biotechnology, particularly in pharmaceutical innovations and in addressing veteran medical concerns. There is so much that can be done in Virginia and the industry there is looking to expand more to get under the radar of investors who can help make the industry flourish even more. Learn more about Dr. Crystal Icenhour’s experiences, expertise, and passion in this week’s episode of When Science Speaks. Connect With Mark and When Science Speaks http://WhenScienceSpeaks.com https://bayerstrategic.com/ On Twitter: https://twitter.com/BayerStrategic On Facebook: https://www.facebook.com/Bayer-Strategic-Consulting-206102993131329 On YouTube: http://bit.ly/BSConTV On LinkedIn: https://www.linkedin.com/in/markdanielbayer/ On Instagram: https://www.instagram.com/bayerstrategic/ On Medium: https://medium.com/@markbayer17 Subscribe to When Science Speaks on Apple Podcasts or Stitcher

Dr. Crystal Icenhour, PhD Crystal R Icenhour, PhD, is one of the rising stars of American biotechnology. After more than 25 years in medical research and biotech, she was named founding CEO of Aperiomics, a company that harnesses the power of next-generation DNA sequencing to identify any known pathogen (bacteria, virus, fungi or parasite). Aperiomics is the only company of its kind and scope in the world. Throughout Dr. Icenhour’s career, she has demonstrated strong leadership in business and science and has dedicated herself to “bridging the translational gap between these two worlds.” What you will learn from this episode: 1) How to use DNA sequencing to find out what is making you sick 2) Is candida and Lyme a real problem? 3) What the difference is between culturing bacteria and identifying them using the technology of Aperiomics 4) How to use stool microbiome testing to figure out what is causing your chronic symptoms 5) Where the future of pathogen identification is going How to learn more about our guest: Name: Dr. Crystal Icenhour, PhD. Company:Aperiomics Job Title/Role: CEO and Co-Founder Address: 45925 Horseshoe Dr. (Suite 170), Sterling, Virginia 20166 Email address: Aperiomics@Waxmanstrategies.com PR Contact Phone number: +1 (202) 802-0504 Twitter handle: @Aperiomics Website:https://aperiomics.com/ About Aperiomics: The only company of its kind and scope in the world combining advanced DNA testing, the power of big data and decades of infectious disease expertise, Aperiomics is revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using its proprietary, world-renowned database containing over 37,000 microorganisms. Helping doctors and their patients identify the causes of infections that other tests cannot identify, Aperiomics streamlines the path to a positive clinical outcome. Responsible for solving more than 1,000 medical mysteries, patients and their physicians often contact Aperiomics after suffering with medical conditions for years and hearing about Aperiomics’ life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018. Please enjoy, share, rate and review our podcast and help us bring the message about precision health care to the world! Dr. Crystal Icenhour, PhD, is one of the rising stars of American biotechnology. After more than 25 years in medical research and biotech, she was named founding CEO of Aperiomics, a company that harnesses the power of next-generation DNA sequencing to identify any known pathogen (bacteria, virus, fungi or parasite). Aperiomics is the only company of its kind and scope in the world. Throughout Dr. Icenhour’s career, she has demonstrated strong leadership in business and science and has dedicated herself to “bridging the translational gap between these two worlds.” What you will learn from this episode: 1) How to use DNA sequencing to find out what is making you sick 2) Is candida and Lyme a real problem? 3) What the difference is between culturing bacteria and identifying them using the technology of Aperiomics 4) How to use stool microbiome testing to figure out what is causing your chronic symptoms 5) Where the future of pathogen identification is going How to learn more about our guest: Name: Dr. Crystal Icenhour, PhD. Company:Aperiomics Job Title/Role: CEO and Co-Founder Address: 45925 Horseshoe Dr. (Suite 170), Sterling, Virginia 20166 Email address: Aperiomics@Waxmanstrategies.com PR Contact Phone number: +1 (202) 802-0504 Twitter handle: @Aperiomics Website:https://aperiomics.com/ About Aperiomics: The only company of its kind and scope in the world combining advanced DNA testing, the power of big data and decades of infectious disease expertise, Aperiomics is revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using its proprietary, world-renowned database containing over 37,000 microorganisms. Helping doctors and their patients identify the causes of infections that other tests cannot identify, Aperiomics streamlines the path to a positive clinical outcome. Responsible for solving more than 1,000 medical mysteries, patients and their physicians often contact Aperiomics after suffering with medical conditions for years and hearing about Aperiomics’ life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018. Please enjoy, share, rate and review our podcast and help us bring the message about precision health care to the world!

The BioScience Talks Impact Series focuses on the path from newly gained scientific knowledge to real-world effects, addressing questions such as How does a new vaccine find its way to physicians' offices? How do ecological discoveries result in new natural resource management paradigms? How do gene-editing techniques move from discovery to therapy? By following novel research discoveries from the lab and field to law books and store shelves, we find the answers and highlight the many ways that scientific research improves our lives. In this inaugural episode, we interviewed Dr. Crystal Icenhour, CEO of Aperiomics, a life sciences company located in Loudoun County, Virginia. The company uses a technique called shotgun metagenomic sequencing identify every known bacteria, virus, fungus, and parasite (over 37,000) found in a given patient sample. Through this revolutionary technique, they are able to identify pathogens that would escape detection using traditional means. We chatted about the technology itself, and just as important, the pathway from innovation to helping patients in need. Learn more about Aperiomics. Subscribe on iTunes. Subscribe on Stitcher. Catch up with us on Twitter..  

For the first time in a long time the expected lifespan of American adults is going in the wrong direction, which is why our co-hosts Frank Gruber, Jen Consalvo, Rich Maloy and Lori Thiel have dedicated this 11th episode of the Startup of the Year Podcast to discussing the booming health tech movement and some of the startups attacking this problem in innovative ways. Specifically, Jessie, an on-demand digital clinic for women; Phylomics, which uses routine blood draws to detect multiple types of cancers before symptoms even appear; NeuroFlow, which enables behavioral health access and engagement across the continuum of care; and Etta Epidermis, an artificially intelligent skin cancer detection software program. Frank was able to recently connect with Crystal Icenhour, Ph.D., the CEO and co-founder of 2018 Startup of the Year winner Aperiomics, which provides a service that identifies every single known bacteria, virus, parasite, and fungus from clinical samples in order to give health care providers the best possible information so that they in turn can give better patient care. Over the course of their conversation, they touch on everything from the importance of understanding the science of how our bodies work, the future of personalized medicine, the vital role gut bacteria plays in our overall health, how to deal with bad actors, and why she never wears black turtlenecks. Grab a kombucha and check it out! And don’t forget to join us in Memphis October 14-16 for the 2019 Startup of the Year Competition & Summit!

On this week’s Tech Nation, Moira speaks with UC San Francisco professor Dr. Louise Aronson talks about a new stage of life: Elderhood, – Redefining Aging, Transforming Medicine, Reimaging Life. With modern technology, it lasts longer than anyone imagined. Also, Tech Nation Health Chief Correspondent Daniel Kraft talks about the Internet of Medical Things, while Dr. Crystal Icenhour, the CEO of Aperiomics, talks about identifying hard-to-diagnose medical conditions by looking at the DNA of microorganisms in your body.

On this week’s Tech Nation, Moira speaks with UC San Francisco professor Dr. Louise Aronson talks about a new stage of life: Elderhood, – Redefining Aging, Transforming Medicine, Reimaging Life. With modern technology, it lasts longer than anyone imagined. Also, Tech Nation Health Chief Correspondent Daniel Kraft talks about the Internet of Medical Things, while Dr. Crystal Icenhour, the CEO of Aperiomics, talks about identifying hard-to-diagnose medical conditions by looking at the DNA of microorganisms in your body.

On this week’s Tech Nation, Moira speaks with UC San Francisco professor Dr. Louise Aronson talks about a new stage of life: Elderhood, – Redefining Aging, Transforming Medicine, Reimaging Life. With modern technology, it lasts longer than anyone imagined. Also, Tech Nation Health Chief Correspondent Daniel Kraft talks about the Internet of Medical Things, while Dr. Crystal Icenhour, the CEO of Aperiomics, talks about identifying hard-to-diagnose medical conditions by looking at the DNA of microorganisms in your body.

Crystal R. Icenhour, PhD., CEO and Co-Founder of Aperiomics joins Rich Bendis to discuss their Technology, Growth, and place in the BioHealth Capital Region  

First on the show this week is Crystal R. Icenhour, PhD, CEO and Co-Founder of Aperiomics. Crystal Icenhour is one of the rising stars of American biotechnology.  After more than 25 years in medical research and biotech, she was named founding CEO of Aperiomics, a company that harnesses the power of next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test. Aperiomics is the only company of its kind and scope in the world! She talks with Marilyn about what led her to this career and the very unique and important work that she and her company are doing. Then Marilyn talks to another remarkable woman that is doing great things for the world – Megan Shea, co-founder of The Soulfull Project. The Soulfull Project, a B Corp certified company whose mission is to make wholesome, nourishing food accessible to all and increase community engagement. For every serving of The Soulfull Project’s hot cereal purchased a serving is donated to a food bank in the same region.  The Soulfull Project launched as a small test in August 2016 in Philadelphia and New Jersey with 3 giving partners and has quickly expanded.  In its first 18 months, The Soulfull Project has expanded nationally to 200 food bank partners, over 2,000 retail locations, and over p00,000 servings going to food banks around the country. Prior to The Soulfull Project, Megan held a variety of marketing and sales roles at Nestle USA in Los Angeles with a focus on kids beverages and at The Campbell Soup Company in Camden, NJ in innovation.  In 2018, Megan was named a Top 50 women in business in New Jersey by NJBiz Magazine.

Hosts and Guest Expert, McKeever Conwell of TEDCO, discuss with Dr. Crystal Icenhour, CEO of Aperiomics, the considerations in structuring a second round (Series A) of funding, including how much to raise, amount of equity to give up, and leverage in terms.